T. Rowe Price Investment Management, Inc. Abbott Laboratories Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 140,542 shares of ABT stock, worth $15.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,542
Previous 99,894
40.69%
Holding current value
$15.9 Million
Previous $11.4 Million
28.62%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,137Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.43 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.14 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.49 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...